NEWTOWN, PA — Helius Medical Technologies, Inc. (Nasdaq: HSDT) has announced its first acquisition of Solana (SOL) tokens, marking the company’s entry into digital asset treasury management with a principal focus on the Solana blockchain. The move positions Helius as both a medical technology company and a strategic participant in blockchain finance.
The company disclosed that it now holds over 760,190 SOL at an average cost basis of $231, representing an investment of roughly $175 million. Alongside its crypto holdings, Helius maintains more than $335 million in cash, earmarked for continued expansion of its Solana strategy and additional token purchases.
Executives framed the acquisition as a long-term bet on Solana’s ecosystem. “The initial accumulation at a lower cost basis than recent market prices, while still retaining the large majority of its capital raised for more opportunistic purchases, showcases how laser focused the team is on maximizing shareholder value,” said Cosmo Jiang, Board Observer at HSDT and General Partner at Pantera Capital.
Helius Executive Chairman Joseph Chee added that the initiative has already gained support from participants in the Solana network, including staking providers and decentralized finance (DeFi) protocols.
Solana, one of the fastest growing blockchains, has processed more than 23 billion transactions this year, averaging 3.7 million daily active wallets and sustaining speeds of over 3,500 transactions per second. Its ~7% native staking yield distinguishes it from non-yield-bearing digital assets such as bitcoin, further reinforcing its appeal for treasury strategies.
While the company remains committed to its neurotechnology and medical device operations, the Solana strategy signals a diversification of focus, underscoring Helius’s intent to leverage blockchain as a core financial and strategic asset.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.